Donald Trump plans to impose new tariffs on pharmaceuticals and semiconductors to boost manufacturing in the US.

The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...

Merck KGaA closed the divestment of its global Surface Solutions business to Global New Material International Holdings Ltd. ...

MRK scores an A+ grade for Profitability, aided by high gross and EBITDA margins of 78% and 46%, respectively. Moreover, it ...

Gemini Insurance is under fire after a $2.5 million settlement claim, with Merck and Jones Lang LaSalle demanding coverage ...

Resting-state EEG (RS-EEG) has emerged as a non-invasive, low-cost tool for Alzheimer’s disease (AD) diagnosis and ...

AI cloud firm CoreWeave is buying an entire tech and life science campus where it previously leased a single data center.

Merck & Co., Inc. (NYSE:MRK) is one of the top cheap pharmaceutical stocks to buy now. Goldman Sachs analyst Asad Haider ...

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...

The stock's rise snapped a four-day losing streak.

We recently published 13 Stocks That Jim Cramer Recently Talked About. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim ...

President Donald Trump escalated his campaign to pressure pharmaceutical companies to lower drug prices, sending letters to 17 of the world’s largest drugmakers demanding they charge the U.S. what oth ...